Johnson & Johnson

Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.


$480M J&J deal heats up neuro-device market

Johnson & Johnson said Monday it plans to bolster its lineup of stroke-prevention products by buying Micrus Endovascular Corp. for about $480 million, marking the latest deal in a neurovascular-device market that appears to be heating up.

J&J’s planned purchase of San Jose, Calif.-based Micrus comes weeks after rival Covidien PLCĀ  announced plans to buy ev3 Corp. , a Micrus rival, for $2.6 billion. Leerink Swann analyst Rick Wise said the Covidien-ev3 combination may have spurred on J&J amid a trend of focusing more on bundled portfolios of products. Get the full story »

Recall of odd-smelling Tylenol, Motrin expanded

Johnson & Johnson is expanding a recall of over-the-counter drugs including Tylenol and Motrin IB because of a musty or moldy smell.

The McNeil Consumer Healthcare business says it is recalling 21 lots of over-the-counter drugs sold in the U.S., Puerto Rico, Fiji, Guatemala, Dominican Republic, Trinidad and Tobago and Jamaica. Get the full story »